| 142 Patients (%) | |
---|---|---|
Mean age (years), (range) | 70.0 (37 to 94) | |
Gender ratio (f/m) | 1 : 1 | (50:50) |
Localization | Â | Â |
 Cecum | 19 | (13.4) |
 Right hemicolon | 37 | (26.1) |
 Transverse colon | 20 | (14.1) |
 Left hemicolon | 8 | (5.6) |
 Sigmoid colon | 58 | (40.8) |
Comorbidities | 117 | (82.4) |
Emergency surgery | 25 | (17.6) |
ASA Score | Â | Â |
 1 to 2 | 71 | (50.0) |
 3 to 4 | 71 | (50.0) |
Tumor characterization | Â | Â |
 T1 | 3 | (2.1) |
 T2 | 14 | (9.9) |
 T3 | 64 | (45.1) |
 T4 | 61 | (43.0) |
 R1/2 | 10 | (7.0) |
 N1 | 80 | (56.3) |
 N2 | 62 | (43.7) |
 Lymph nodes examined | 23.16 | ± 9.33 |
 Lymph nodes positive | 4.04 | ± 4.15 |
 V0 | 73 | (51.4) |
 L0 | 76 | (53.5) |
 G1/2 | 111 | (78.2) |
Adjuvant chemotherapy | 126 | (88.7) |
Follow-up (years) | 3.85 | ±2.81 |
Recurrence | 48 | (33.8) |
Died of disease | 43 | (30.3) |